Abstract:The review starts by describing the signaling pathways linked to MI and its postoperative complications. It then summarizes the potential of herbs and their active ingredients in preventing and treating MI and its complications over the past 5 years, with emphasis on their specific mechanisms of action. Myocardial infarction (MI) is a prevalent disease with high mortality rates worldwide. The course of MI is intricate and variable, necessitating personalized treatment strategies based on different mechanisms. However, variety of postoperative complications and rejections, such as heart failure, arrhythmias, cardiac rupture, and left ventricular thrombus, contribute to a poor prognosis. Despite the inclusion of antiplatelet agents and statins in the conventional treatment regimen, their clinical applicability is constrained by potential adverse effects and limited efficacy. Additionally, the mechanisms leading to MI are complex and diverse. Therefore, the development of novel compounds for MI treatment. The use of traditional Chinese medicine (TCM) in the prevention and treatment of cardiovascular diseases, including MI, is grounded in its profound historical background, comprehensive theoretical system, and accumulated knowledge. An increasing number of contemporary evidence‐based medical studies have demonstrated that TCM plays a significant role in alleviating symptoms and improving the quality of life for MI patients. Chinese herbal formulations and active ingredients can intervene in the pathological process of MI through key factors such as inflammation, oxidative stress, apoptosis, ferroptosis, pyroptosis, myocardial fibrosis, angiogenesis, and autophagy. This article critically reviews existing herbal formulations from an evidence‐based medicine perspective, evaluating their research status and potential clinical applications. Additionally, it explores recent advancements in the use of herbal medicines and their components for the prevention and treatment of MI, offering detailed insights into their mechanisms of action.

Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis

Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway

Natural Products from Traditional Chinese Medicine for the Prevention and Treatment of Heart Failure: Progress and Perspectives.

Non-coding RNAs in cardiac ﬁbrosis: emerging biomarkers and therapeutic targets.

Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms

Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine

Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment

Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

A Series of Methods for Screening and Evaluating Potential Anti-Cardiovascular Drugs from Traditional Chinese Herbs

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis

Chinese Herbal Medicine Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating Endoplasmic Reticulum Stress

Non‐coding RNAs in Cardiomyocyte Proliferation and Cardiac Regeneration: Dissecting Their Therapeutic Values

Noncoding RNAs and Cardiac Fibrosis

Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine

Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases

Epigenetic signatures in cardiac fibrosis: Focusing on noncoding RNA regulators as the gatekeepers of cardiac fibroblast identity

Research Progress of Traditional Chinese Medicine Based on TGF-β/Smad Signal Pathway in Preventing and Treating Myocardial Fibrosis in Heart Failure

[Progress in integrative Chinese and Western medicine study on prevention and treatment of myocardial fibrosis].

The roles of long noncoding RNAs (lncRNAs) in myocardial pathophysiology.

Therapeutic Potential of Chinese Herbal Medicine and Underlying Mechanism for the Treatment of Myocardial Infarction